Desq Long
Sign in

Company

Imunon, Inc.

IMNN · CIK 0000749647

SEC FORM 4
$6,190.17

Imunon, Inc. (IMNN)

Acquisition (code A) of 4,211 shares at $1.47 per share.

Reporting Person Faller Douglas Vincent · Officer Title Chief Medical Officer · Transaction Code A

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001437749-26-030413 · filed 2026-09-15 · View filing →

SEC FORM 4
$8,090.88

Imunon, Inc. (IMNN)

Acquisition (code A) of 5,504 shares at $1.47 per share.

Reporting Person Lindborg Stacy · Officer Title President and CEO · Transaction Code A

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001437749-26-030414 · filed 2026-09-15 · View filing →

SEC FORM 4
$8,561.28

Imunon, Inc. (IMNN)

Acquisition (code A) of 5,824 shares at $1.47 per share.

Reporting Person Tardugno Michael H · Officer Title Executive Chairman of Board · Transaction Code A

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001437749-26-030415 · filed 2026-09-15 · View filing →

SEC FORM 4
$3,949.86

Imunon, Inc. (IMNN)

Sale of 2,525 shares at $1.5643 per share.

Reporting Person Eylward Susan · Officer Title General Counsel and Corp Sec · Transaction Code S

Traded Aug 31, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0001437749-26-029405 · filed 2026-09-01 · View filing →

SEC FORM 4
$4,040.00

Imunon, Inc. (IMNN)

Acquisition (code A) of 2,525 shares at $1.60 per share.

Reporting Person Eylward Susan · Officer Title General Counsel and Corp Sec · Transaction Code A

Traded Aug 28, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0001437749-26-029405 · filed 2026-09-01 · View filing →

SEC FORM 4
$5,801.60

Imunon, Inc. (IMNN)

Acquisition (code A) of 3,626 shares at $1.60 per share.

Reporting Person Faller Douglas Vincent · Officer Title Chief Medical Officer · Transaction Code A

Traded Aug 28, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0001437749-26-029407 · filed 2026-09-01 · View filing →

SEC FORM 4
$10,915.20

Imunon, Inc. (IMNN)

Acquisition (code A) of 6,822 shares at $1.60 per share.

Reporting Person Lindborg Stacy · Officer Title President and CEO · Transaction Code A

Traded Aug 28, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0001437749-26-029408 · filed 2026-09-01 · View filing →

SEC FORM 4
$11,793.60

Imunon, Inc. (IMNN)

Acquisition (code A) of 7,371 shares at $1.60 per share.

Reporting Person Tardugno Michael H · Officer Title Executive Chairman of Board · Transaction Code A

Traded Aug 28, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0001437749-26-029409 · filed 2026-09-01 · View filing →

SEC FORM 4
$3,992.60

Imunon, Inc. (IMNN)

Sale of 2,449 shares at $1.6303 per share.

Reporting Person Eylward Susan · Officer Title General Counsel and Corp Sec · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001437749-26-028184 · filed 2026-08-17 · View filing →

SEC FORM 4
$4,040.85

Imunon, Inc. (IMNN)

Acquisition (code A) of 2,449 shares at $1.65 per share.

Reporting Person Eylward Susan · Officer Title General Counsel and Corp Sec · Transaction Code A

Traded Aug 14, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001437749-26-028184 · filed 2026-08-17 · View filing →

SEC FORM 4
$11,792.55

Imunon, Inc. (IMNN)

Acquisition (code A) of 7,147 shares at $1.65 per share.

Reporting Person Tardugno Michael H · Officer Title Executive Chairman of Board · Transaction Code A

Traded Aug 14, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001437749-26-028185 · filed 2026-08-17 · View filing →

SEC FORM 4
$5,801.40

Imunon, Inc. (IMNN)

Acquisition (code A) of 3,516 shares at $1.65 per share.

Reporting Person Faller Douglas Vincent · Officer Title Chief Medical Officer · Transaction Code A

Traded Aug 14, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001437749-26-028186 · filed 2026-08-17 · View filing →

SEC FORM 4
$10,914.75

Imunon, Inc. (IMNN)

Acquisition (code A) of 6,615 shares at $1.65 per share.

Reporting Person Lindborg Stacy · Officer Title President and CEO · Transaction Code A

Traded Aug 14, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001437749-26-028187 · filed 2026-08-17 · View filing →